Democrats drove their election-year economic package toward Senate approval early Sunday, debating a measure with less ambition than U.S. President Joe Biden's original domestic vision. Still, it touches deep-rooted party dreams of slowing global warming, moderating pharmaceutical costs and taxing immense corporations.
Debate began Saturday and by early Sunday morning, Democrats had swatted down over a dozen Republican amendments designed to torpedo the legislation or create campaign ads attacking Democratic senators. Despite unanimous GOP opposition, Democratic unity in the 50-50 chamber -- buttressed by Vice President Kamala Harris' tiebreaking vote -- suggested the party was on track for a morale-boosting victory three months from elections when congressional control is at stake.
Republicans said the measure would undermine an economy that policymakers are struggling to keep from plummeting into recession. They said the bill's business taxes would hurt job creation and force prices skyward, making it harder for people to cope with the nation's worst inflation since the 1980s.
Even so, the new measure gives Democrats a campaign-season showcase for action on coveted goals. It includes the largest ever federal effort on climate change -- close to $400 billion -- hands Medicare the power to negotiate pharmaceutical prices and extends expiring subsidies that help 13 million people afford health insurance.
Progressive Sen. Bernie Sanders, I-Vt., offered amendments to further expand the legislation's health benefits, and those efforts were defeated. Most votes were forced by Republicans and many were designed to make Democrats look soft on U.S.-Mexico border security and gasoline and energy costs, and like bullies for wanting to strengthen IRS tax law enforcement.
But the thrust of their pharmaceutical price language remained. That included letting Medicare negotiate what it pays for drugs for its 64 million elderly recipients, penalizing manufacturers for exceeding inflation for pharmaceuticals sold to Medicare and limiting beneficiaries out-of-pocket drug costs to $2,000 annually.
Sinema forced Democrats to drop a plan to prevent wealthy hedge fund managers from paying less than individual income tax rates for their earnings. She also joined with other Western senators to win $4 billion to combat the region's drought.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Democrats push Biden climate, health priorities toward approval in the SenateDemocratic unity in the senate suggests the party was on track for a morale-boosting victory three months from elections when congressional control is at stake
Read more »
Biden tests negative for COVID, isolating until second negativeDr. Kevin O’Connor wrote that the president will maintain strict isolation out of ‘an abundance of caution’
Read more »
Biden tests negative for COVID, isolating until 2nd negativePresident Joe Biden tested negative for COVID-19 on Saturday but will continue to isolate at the White House until a second negative test, his doctor said.
Read more »
U.S. President Joe Biden tests negative for COVID-19 following rebound caseU.S. President Joe Biden has tested negative for COVID-19 but will remain in isolation pending a second test, his physician announced in a letter Saturday.
Read more »
Biden tests negative for COVID, White House physician saysThe Democratic president, “in an abundance of caution,” will remain in isolation until he tests negative on a second test.
Read more »